Beneficial Effects of High Dietary Fiber Intake in Patients with Type 2 Diabetes Mellitus
Manisha Chandalia, M.D., Abhimanyu Garg, M.D., Dieter Lutjohann, Ph.D., Klaus von Bergmann, M.D., Scott M. Grundy, M.D., Ph.D., and Linda J. Brinkley, R.D.
Background The effect of increasing the intake of dietary fiberon glycemic control in patients with type 2 diabetes mellitusis controversial.
Methods In a randomized, crossover study, we assigned 13 patientswith type 2 diabetes mellitus to follow two diets, each forsix weeks: a diet containing moderate amounts of fiber (total,24 g; 8 g of soluble fiber and 16 g of insoluble fiber), asrecommended by the American Diabetes Association (ADA), anda high-fiber diet (total, 50 g; 25 g of soluble fiber and 25g of insoluble fiber) containing foods not fortified with fiber(unfortified foods). Both diets, prepared in a research kitchen,had the same macronutrient and energy content. We compared theeffects of the two diets on glycemic control and plasma lipidconcentrations.
Results Compliance with the diets was excellent. During thesixth week of the high-fiber diet, as compared with the sixthweek of the ADA diet, mean daily preprandial plasma glucoseconcentrations were 13 mg per deciliter (0.7 mmol per liter)lower (95 percent confidence interval, 1 to 24 mg per deciliter[0.1 to 1.3 mmol per liter]; P=0.04) and mean daily urinaryglucose excretion was 1.3 g lower (median difference, 0.23 g;95 percent confidence interval, 0.03 to 1.83; P=0.008). Thehigh-fiber diet also lowered the area under the curve for 24-hourplasma glucose and insulin concentrations, which were measuredevery two hours, by 10 percent (P=0.02) and 12 percent (P=0.05),respectively. The high-fiber diet reduced plasma total cholesterolconcentrations by 6.7 percent (P=0.02), triglyceride concentrationsby 10.2 percent (P=0.02), and very-low-density lipoprotein cholesterolconcentrations by 12.5 percent (P=0.01).
Conclusions A high intake of dietary fiber, particularly ofthe soluble type, above the level recommended by the ADA, improvesglycemic control, decreases hyperinsulinemia, and lowers plasmalipid concentrations in patients with type 2 diabetes.
Dietary guidelines for patients with diabetes mellitus wererevised by the American Diabetes Association (ADA) earlier thisyear.1 The ADA recommends that the composition of the diet beindividualized on the basis of a nutritional assessment andthe outcomes desired. Consistent with the previous recommendationsof the ADA,2 the new guidelines advise replacing saturated fatwith carbohydrates. However, on the basis of previous studies,3,4,5,6,7,8,9,10an alternative approach of replacing saturated fat with cismonounsaturated fat was also included in the recommendations.1This new approach is further supported by epidemiologic studiesthat have shown the healthful effects of diets rich in cis monounsaturatedfat in Mediterranean countries.11,12
Another, less strongly emphasized aspect of Mediterranean dietsis the high intake of fruits, vegetables, and grains that arerich sources of dietary fiber.13,14 The ADA recommended a moderateincrease in the intake of dietary fiber to 20 to 35 g per daybecause of the cholesterol-lowering effects of soluble fiber.However, the effects of dietary fiber on glycemic control wereconsidered inconsequential.1 Furthermore, the expert panel ofthe ADA considered it difficult to achieve a high dietary intakeof soluble fiber without consuming foods or supplements fortifiedwith fiber.1 We therefore designed the present study to determinethe effects on glycemic control and plasma lipid concentrationsof increasing the intake of dietary fiber in patients with type2 diabetes exclusively through the consumption of foods notfortified with fiber (unfortified foods) to a level beyond thatrecommended by the ADA. In addition, we studied the effectsof such an intervention on the intestinal absorption of cholesteroland the fecal excretion of sterols in an attempt to uncoverthe mechanisms by which a high-fiber diet lowers plasma cholesterol.
Methods
Patients
We studied 12 men and 1 woman (9 non-Hispanic whites and 4 blacks)with type 2 diabetes at the general clinical research centerof the University of Texas Southwestern Medical Center at Dallas.The protocol for the study was approved by the institutionalreview board of the medical center, and each patient gave writteninformed consent. In all patients the onset of diabetes wasinsidious; the disease developed in most of the patients after40 years of age. Their mean (±SD) age was 61±9years (range, 45 to 70). Their mean body weight was 93.5±12.7kg, and the mean body-mass index (the weight in kilograms dividedby the square of the height in meters) was 32.3±3.9.Three patients were treated with diet alone, and the other 10patients were treated with 2.5 to 20 mg of glyburide daily inaddition to diet. The dose of glyburide was not changed duringthe study.
On entry into the study, the patients' plasma cholesterol andtriglyceride concentrations after an overnight fast ranged from151 to 324 mg per deciliter (3.90 to 8.38 mmol per liter) and67 to 390 mg per deciliter (0.76 to 4.40 mmol per liter), respectively,and their fasting plasma glucose concentrations were less than200 mg per deciliter (11.1 mmol per liter). Their glycosylatedhemoglobin values ranged from 6.0 to 9.8 percent. Two patientshad a history of coronary heart disease, but none had recentlyhad a myocardial infarction, unstable angina pectoris, or congestiveheart failure. Also, none had thyroid, renal, or hepatic disease.None of the patients were receiving lipid-lowering therapy.
Design of the Study
All the patients were first admitted to the general clinicalresearch center for five days (the base-line period), duringwhich a detailed history was taken, a physical examination wasperformed, and laboratory tests were performed. After the base-lineperiod, all the patients received both the ADA diet and thehigh-fiber diet, each diet for a period of six weeks. Six patientsreceived the high-fiber diet first, and the other seven receivedthe ADA diet first. There was a median interval of seven daysbetween the two study periods, during which the patients wereinstructed to consume an isocaloric diet. During the last weekof each dietary period (days 36 to 42), the patients were hospitalizedfor evaluation.
On weekdays, all the patients ate at least one meal (breakfast,lunch, or dinner) at the general clinical research center. Othermeals were supplied in packages so that they could be consumedat home. The dietitian monitored compliance by interviewingthe patients. The patients were instructed to bring back anyunconsumed food and to maintain a constant level of physicalactivity throughout the study.
Blood for lipid analyses was drawn, after an overnight fast,daily for two days before the institution of the study dietand daily on days 38 through 42 during both dietary periods.Plasma glucose was measured at 7 and 11 a.m. and at 4 and 8p.m. each day during the base-line period and on days 38 through42 of both dietary periods. Glycosylated hemoglobin was measuredduring the base-line period and at the end of each dietary period.On the last day of each dietary period, blood samples were obtainedevery two hours for measurements of plasma glucose and insulin.On days 38 through 42, patients collected 24-hour urine specimensfor quantitative determination of glucose.
To permit us to determine fecal sterol balance and the percentageof cholesterol absorption, each patient took a capsule containing30 mg of sitostanol, 3 mg of [26,26,26,27,27,27-2H6]-cholesterol,and 3 mg of [5,6,22,23-2H4]-sitostanol (Medical Isotopes, Pelham,N.H.) three times a day on days 36 through 42. Fecal sampleswere collected on day 35 or 36 and on the last three days ofeach dietary period. Fecal samples were frozen within 12 hoursafter collection and were pooled for analysis of small aliquots.
Diets
The composition of the study diets is shown in Table 1. Thecomposition of the diets was calculated by means of a softwareprogram based on the Department of Agriculture Handbook Series8 (Nutriplanner, Practocare, San Diego, Calif.).15 The contentof total as well as soluble and insoluble dietary fiber wasestimated according to the data provided in the CRC Handbookof Dietary Fiber in Human Nutrition.16 Both diets consistedof unfortified foods. The patients were allowed some choicesof food items. Both diets provided 15 percent of the total energyas protein, 55 percent as carbohydrate, and 30 percent as fat;saturated, cis monounsaturated, and polyunsaturated fats accountedfor 7 percent, 17 percent, and 6 percent of the total energy,respectively.
The high-fiber diet provided 50 g of total fiber per day; solubleand insoluble fiber content provided 25 g each. The ADA dietcontained 24 g of total fiber per day, with 8 g as soluble fiberand 16 g as insoluble fiber. Unfortified foods, particularlythose rich in soluble fiber, such as cantaloupe, grapefruit,orange, papaya, raisins, lima beans, okra, sweet potato, wintersquash, zucchini, granola, oat bran, and oatmeal, were usedto achieve high-fiber intake. No fiber supplements were used.Sample menus of both the study diets are shown in Table 2. Theindividual foods were weighed daily during meal preparationin the research kitchen of the general clinical research center.
Fasting plasma total cholesterol, lipoprotein cholesterol, andtriglycerides were measured according to the procedures of theLipid Research Clinics.17 Cholesterol and triglycerides weremeasured enzymatically with the use of kits (Boehringer Mannheim,Indianapolis). Very-low-density lipoproteins (VLDLs) (density,less than 1.006 g per milliliter) were removed by ultracentrifugation,and cholesterol was measured in the VLDL fraction and the infranatant.High-density-lipoprotein (HDL) cholesterol was measured enzymaticallyafter lipoproteins containing apolipoprotein B had been precipitatedwith heparinmanganese. Cholesterol in the low-densitylipoprotein (LDL) fraction was estimated to be the differencebetween the cholesterol content of the infranatant and thatof the HDL fraction.
Plasma and urinary glucose were measured by the glucose oxidasemethod (Beckman Glucose Analyzer, Beckman Instruments, Fullerton,Calif.). Glycosylated hemoglobin was measured with ion-exchangehigh-performance liquid chromatography (Bio-Rad Laboratories,Hercules, Calif.). Plasma insulin was measured by radioimmunoassay.18,19
Pooled fecal samples collected within the last week of eachdietary period were prepared for analysis of neutral and acidicfecal sterols as described previously.20 Gasliquid chromatographyof neutral and acidic fecal sterols was performed on a gas chromatograph(model HP5890, HewlettPackard, Palo Alto, Calif.) equippedwith an automatic sample injector. Cholesterol absorption wasmeasured during the same period from fecal samples by gasliquidchromatography and mass spectrometry.21
Statistical Analysis
To compare the two study periods and to assess the effect ofthe sequence in which the patients received the high-fiber andADA diets, we used repeated-measures analysis of variance.22For skewed data, we used the Wilcoxon signed-rank test to comparethe two dietary periods.23
Results
The compliance with both the study diets was excellent, accordingto interviews with the patients and estimates of the energycontent of any leftover foods. Three patients reported consumingextra food on one day during the study, two while eating thehigh-fiber diet and one the ADA diet. The patients commentedabout the larger quantities of food in the high-fiber diet,but they consumed all the food given to them. The results arepresented irrespective of the order of the diets, because thesequence of the diets had no effect on the results.
During the last week of each study period, the patients in bothgroups had similar daily energy intakes and body weights andreceived a similar dose of glyburide (Table 3). The mean plasmaglucose concentration was lower (by 13 mg per deciliter [0.7mmol per liter], or 8.9 percent) when patients completed thehigh-fiber diet than when they completed the ADA diet (P=0.04),and mean daily urinary glucose excretion was 1.3 g lower (P=0.008).Daily plasma glucose concentrations were 10 percent lower withthe high-fiber diet than with the ADA diet (values for the areaunder the curve, 3743±944 vs. 3365± 1003 mg ·hour per deciliter [207.8±52.4 vs. 186.8± 55.7mmol · hour per liter]; P=0.02), and plasma insulin concentrationswere 12 percent lower (values for the area under the curve,1107±650 vs. 971± 491 µU · hour permilliliter [6642±3900 vs. 5826± 2946 pmol ·hour per liter]; P=0.05) (Figure 1). Glycosylated hemoglobinvalues were slightly lower after the high-fiber diet (P=0.09).
Figure 1. Mean (±SE) 24-Hour Profile of Plasma Glucose Concentrations (Panel A) and Insulin Concentrations (Panel B) during the Last Day of the American Diabetes Association (ADA) Diet and the Last Day of the High-Fiber Diet in 13 Patients with Type 2 Diabetes Mellitus.
The arrows indicate the times at which the main meals and a snack were consumed during the day. To convert values for glucose to millimoles per liter, multiply by 0.056. To convert values for insulin to picomoles per liter, multiply by 6.
As compared with the ADA diet, the high-fiber diet resultedin a lower fasting plasma total cholesterol concentration (by6.7 percent, P=0.02), a lower plasma triglyceride concentration(by 10.2 percent, P=0.02), and a lower plasma VLDL cholesterolconcentration (by 12.5 percent, P=0.01) (Table 4). The fastingplasma LDL cholesterol concentration was 6.3 percent lower withthe high-fiber diet (P=0.11). There were no significant differencesbetween the two diets in terms of the fasting plasma HDL cholesterolconcentration.
Table 4. Fasting Plasma Lipid and Lipoprotein Concentrations during the Last Week of the Study Periods (Days 38 through 42).
As compared with the ADA diet, the high-fiber diet decreasedgastrointestinal absorption of cholesterol by 10 percent (48.5±9.6vs. 43.7±7.4 percent; 95 percent confidence intervalfor the decrease, 0.6 to 9.0 percent; P=0.03) and increasedfecal acidic sterol excretion by 41 percent (895±301vs. 1258± 458 mg per day; 95 percent confidence intervalfor the increase, 137 to 589 mg per day; P=0.005), but did notsignificantly affect the excretion of neutral sterols (1052±375vs. 1122±565 mg per day; 95 percent confidence intervalfor the difference, 194 to 334 mg per day; P=0.60).
Discussion
The intake of dietary fiber among people living in Western countriesremains low, and according to the Third National Health andNutrition Examination Survey (NHANES), it averages 17 g perday in the United States.24 Although patients with diabetesare advised to increase their intake of dietary fiber, in theNHANES study, their average daily intake was found to be only16 g.24 Why the intake of dietary fiber in patients with diabetesremains low despite its well-documented effect of loweringplasma cholesterol concentrations remains unexplained.It is possible that the controversy about whether there arebeneficial effects of dietary fiber on glycemic control reducesthe enthusiasm of physicians and dietitians for recommendinghigh-fiber diets. The main purpose of our study was to investigatethe effects on glycemic control of increasing the intake ofdietary fiber. To avoid the confounding effects of concomitantchanges in energy and macronutrients, the two study diets wereisocaloric and the macronutrient composition of the diets wasidentical. Furthermore, unfortified foods were used as the sourceof dietary fiber.
Most important, we found that the high-fiber diet improved glycemiccontrol, as evidenced by decreases in the mean daily preprandialand 24-hour plasma glucose concentrations. Urinary glucose excretionwas also lowered by the high-fiber diet. The high-fiber dietlowered glycosylated hemoglobin values slightly but not significantly.The high-fiber diet also lowered 24-hour plasma insulin concentrations.
The results of previous studies that evaluated the role of dietaryfiber on glycemic control in patients with type 2 diabetes wereinconsistent. In some of the studies, the lack of control forconcomitant changes in the intake of macronutrients makes thedata difficult to interpret. For example, in the study by Kiehmet al.25 and in that by Simpson et al.,26 the high-fiber diethad a lower fat and higher carbohydrate content than the low-fiberdiet. In other studies, the interpretation of the results wasconfounded by the short duration of the dietary intervention,27,28,29the lack of random assignment of the sequence of the high-fiberand low-fiber diets,27,29 and unexplained weight loss duringthe high-fiber diet.29
Only a few well-controlled studies have evaluated the glycemiceffects of increasing the intake of dietary fiber with the useof either preparations of refined concentrated fiber or unfortifiedfood, and the results have been inconsistent.1,30 For example,diets that included 15 to 21 g of guar-gum fiber or oat-branconcentrate per day had no effect on glycemic control31,32 orresulted in only a slight improvement.33,34 In randomized, crossovertrials of six weeks' duration in which the intake of dietaryfiber was increased by 16 g per 1000 kcal through the consumptionof foods prepared in a research kitchen or by 14 g per day throughdietary instruction, there was no improvement in glycemic control.35,36In contrast, increasing dietary fiber by 23 g for three weeksand by 30 g for six weeks resulted in decreased fasting andpostprandial plasma glucose concentrations.37,38 We found thatan increase in the intake of total dietary fiber, which consistedpredominantly of soluble fiber, significantly improved glycemiccontrol and decreased the degree of hyperinsulinemia in patientswith type 2 diabetes.
Our study also demonstrates the feasibility of achieving a highintake of dietary soluble fiber by consuming unfortified foods.Our patients accepted the high-fiber diet well and had few sideeffects; therefore, we recommend that patients with diabetesbe encouraged to use unfortified foods instead of less palatablepurified-fiber preparations and supplements to increase theirintake of dietary fiber.
The mechanisms of the improved glycemic control associated withhigh fiber intake remain undefined. Whether this effect is dueto an increase in soluble fiber, insoluble fiber, or both isunclear. Besides causing increased fecal excretion of bile acids,dietary fiber may cause malabsorption of fat.39 However, inour study, the patients' weight did not change with the high-fiberdiet, which suggests that the degree of reduction in the absorptionof fat was insignificant. Another possibility is that dietaryfiber improves glycemic control by reducing or delaying theabsorption of carbohydrates.
As expected, the high-fiber diet reduced plasma total cholesterolconcentrations by 6.7 percent, a finding consistent with theresults of previous reports of the cholesterol-reducing effectsof soluble but not insoluble fiber.40,41 Therefore, the loweringof cholesterol can be attributed primarily to an average increaseof 17 g in the intake of soluble fiber. Previous studies innormal subjects have reported no effects of the amount of dietaryfiber on plasma triglyceride concentrations.42 In our study,the decrease in plasma triglyceride and VLDL cholesterol concentrationsduring the high-fiber diet could have been due to the improvementin glycemic control.
The mechanisms of the reduction in plasma cholesterol concentrationsinduced by the increased dietary fiber intake are controversial,however. The increase in bile-acid excretion probably explainsmost of the reduction, and the reduction in cholesterol absorptionmay also have contributed to this finding. Previous studieshave also reported a variable increase in bile-acid excretionresulting from the consumption of pectin,39,43 oat bran,44,45bagasse,46 and diets with a mixture of soluble fiber and insolublefiber,47 but not psyllium.48 In contrast, Kesaniemi et al.47reported that a high-fiber diet did not change cholesterol absorptionin normal subjects. However, the high-fiber diet they used included26 g of fiber, and it did not lower plasma cholesterol concentrations.47
In conclusion, an increase in the intake of dietary fiber, predominantlyof the soluble type, by patients with type 2 diabetes mellitusimproved glycemic control and decreased hyperinsulinemia inaddition to the expected lowering of plasma lipid concentrations.Therefore, dietary guidelines for patients with diabetes shouldemphasize an overall increase in dietary fiber through the consumptionof unfortified foods, rather than the use of fiber supplements.
Supported in part by grants (M01-RR00633 and HL-29252) fromthe National Institutes of Health and by research grants fromthe Bundesministerium für Bildung, Forschung, Wissenschaftund Technologie (01EC9402) and the Deutsche Forschungsgemeinschaft(BE 1673/1-1).
We are indebted to Angela Osborn, Travis Petricek, and the nursingand dietetic service of the General Clinical Research Centerof the University of Texas Southwestern Medical Center, Dallas,for their excellent technical support and to Beverley Adams-Huet,M.S., for statistical analysis.
Source Information
From the Department of Internal Medicine (M.C., A.G., S.M.G., L.J.B.) and the Center for Human Nutrition (A.G., S.M.G.), University of Texas Southwestern Medical Center, Dallas; the Department of Veterans Affairs Medical Center, Dallas (M.C., A.G., S.M.G.); and the Department of Clinical Pharmacology, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany (D.L., K.B.).
Address reprint requests to Dr. Garg at the Center for Human Nutrition, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390.
References
Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 2000;23:S43-S46.
American Diabetes Association. Nutritional recommendations and principles for individuals with diabetes mellitus: 1986. Diabetes Care 1987;10:126-132. [Medline]
Garg A, Bonanome A, Grundy SM, Zhang Z-J, Unger RH. Comparison of a high-carbohydrate diet with high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1988;319:829-834. [Abstract]
Rivellese AA, Giacco R, Genovese S, et al. Effects of changing amount of carbohydrate in diet on plasma lipoproteins and apolipoproteins in type II diabetic patients. Diabetes Care 1990;13:446-448. [Abstract]
Parillo M, Rivellese AA, Ciardullo AV, et al. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism 1992;41:1373-1378. [CrossRef][Medline]
Rasmussen OW, Thomsen C, Hansen KW, Vesterlund M, Winther E, Hermansen K. Effects on blood pressure, glucose, and lipid levels of a high-monounsaturated fat diet compared with a high-carbohydrate diet in NIDDM subjects. Diabetes Care 1993;16:1565-1571. [Abstract]
Campbell LV, Marmot PE, Dyer JA, Borkman M, Storlien LH. The high-monounsaturated fat diet as a practical alternative for NIDDM. Diabetes Care 1994;17:177-182. [Abstract]
Lerman-Garber I, Ichazo-Cerro S, Zamora-Gonzalez J, Cardoso-Saldana G, Posadas-Romero C. Effect of a high-monounsaturated fat diet enriched with avocado in NIDDM patients. Diabetes Care 1994;17:311-315. [Abstract]
Garg A, Grundy SM, Unger RH. Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM. Diabetes 1992;41:1278-1285. [Abstract]
Garg A, Bantle JP, Henry RR, et al. Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA 1994;271:1421-1428. [Free Full Text]
Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the Seven Countries Study. Am J Epidemiol 1986;124:903-915. [Free Full Text]
Menotti A, Keys A, Aravanis C, et al. Seven Countries Study: first 20-year mortality data in 12 cohorts of six countries. Ann Med 1989;21:175-179. [Medline]
Nestle M. Mediterranean diets: historical and research overview. Am J Clin Nutr 1995;61:Suppl:1313S-1320S. [Abstract]
Kromhout D, Keys A, Aravanis C, et al. Food consumption patterns in the 1960s in seven countries. Am J Clin Nutr 1989;49:889-894. [Free Full Text]
Department of Agriculture, Agricultural Research Service. Composition of foods. Agriculture handbook No. 8. Series 8-1 to 8-16. Washington, D.C.: Government Printing Office, 1976-1987.
Schakel S, Sievert YA, Buzzard IM. Dietary fiber values for common foods. In: Spiller GA, ed. CRC handbook of dietary fiber in human nutrition. 2nd ed. Boca Raton, Fla.: CRC Press, 1993:567-93.
Public Health Service. Manual of laboratory operations: lipid research clinics program: lipid and lipoprotein analysis. 2nd ed. Washington, D.C.: Government Printing Office, 1982.
Herbert V, Lau KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965;25:1375-1384. [Free Full Text]
Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest 1960;39:1157-1175.
Czubayko F, Beumers B, Lammsfuss S, Lutjohann D, von Bergmann K. A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J Lipid Res 1991;32:1861-1867. [Abstract]
Lutjohann D, Meese CO, Crouse JR III, von Bergmann K. Evaluation of deuterated cholesterol and deuterated sitostanol for measurement of cholesterol absorption in humans. J Lipid Res 1993;34:1039-1046. [Abstract]
Jones B, Kenward MG. Design and analysis of crossover trials. London: Chapman & Hall, 1989.
Conover WJ. Practical nonparametric statistics. 2nd ed. New York: John Wiley, 1980:288-92.
National Health and Nutrition Examination Survey III, 1988-94. NCHS CD-ROM series 11. No. 2A. ASCII version. Hyattsville, Md.: National Center for Health Statistics, April 1998.
Kiehm TG, Anderson JW, Ward K. Beneficial effects of a high carbohydrate, high fiber diet on hyperglycemic diabetic men. Am J Clin Nutr 1976;29:895-899. [Free Full Text]
Simpson HCR, Simpson RW, Lousley S, et al. A high carbohydrate leguminous fibre diet improves all aspects of diabetic control. Lancet 1981;1:1-5. [Medline]
Rivellese A, Riccardi G, Giacco A, et al. Effect of dietary fibre on glucose control and serum lipoproteins in diabetic patients. Lancet 1980;2:447-450. [CrossRef][Medline]
Riccardi G, Rivellese A, Pacioni D, Genovese S, Mastranzo P, Mancini M. Separate influence of dietary carbohydrate and fibre on the metabolic control in diabetes. Diabetologia 1984;26:116-121. [CrossRef][Medline]
O'Dea K, Traianedes K, Ireland P, et al. The effects of diet differing in fat, carbohydrate, and fiber on carbohydrate and lipid metabolism in type II diabetes. J Am Diet Assoc 1989;89:1076-1086. [Medline]
Nuttall FQ. Dietary fiber in the management of diabetes. Diabetes 1993;42:503-508. [Abstract]
Holman RR, Steemson J, Darling P, Turner RC. No glycemic benefit from guar administration in NIDDM. Diabetes Care 1987;10:68-71. [Abstract]
Uusitupa M, Siitonen O, Savolainen K, Silvasti M, Penttila I, Parviainen M. Metabolic and nutritional effects of long-term use of guar gum in the treatment of noninsulin-dependent diabetes of poor metabolic control. Am J Clin Nutr 1989;49:345-351. [Free Full Text]
Aro A, Uusitupa M, Voutilainen E, Hersio K, Korhonen T, Siitonen O. Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-independent) diabetes. Diabetologia 1981;21:29-33. [Medline]
Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 1996;96:1254-1261. [CrossRef][Medline]
Hollenbeck CB, Coulston AM, Reaven GM. To what extent does increased dietary fiber improve glucose and lipid metabolism in patients with noninsulin-dependent diabetes mellitus (NIDDM)? Am J Clin Nutr 1986;43:16-24. [Free Full Text]
Manhire A, Henry CL, Hartog M, Heaton KW. Unrefined carbohydrate and dietary fibre in treatment of diabetes mellitus. J Hum Nutr 1981;35:99-101. [Medline]
Karlstrom B, Vessby B, Asp NG, et al. Effects of an increased content of cereal fibre in the diet of type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1984;26:272-277. [Medline]
Hagander B, Asp NG, Efendic S, Nilsson-Ehle P, Schersten B. Dietary fiber decreases fasting blood glucose levels and plasma LDL concentration in noninsulin-dependent diabetes mellitus patients. Am J Clin Nutr 1988;47:852-858. [Free Full Text]
Kay RM, Truswell AS. Effect of citrus pectin on blood lipids and fecal steroid excretion in man. Am J Clin Nutr 1977;30:171-175. [Free Full Text]
Jenkins DJ, Newton C, Leeds AR, Cummings JH. Effect of pectin, guar gum, and wheat fibre on serum-cholesterol. Lancet 1975;1:1116-1117. [Medline]
Hillman LC, Peters SG, Fisher CA, Pomare EW. The effects of the fiber components pectin, cellulose and lignin on serum cholesterol levels. Am J Clin Nutr 1985;42:207-213. [Free Full Text]
Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999;69:30-42. [Free Full Text]
Cummings JH, Southgate DAT, Branch WJ, et al. The digestion of pectin in the human gut and its effect on calcium absorption and large bowel function. Br J Nutr 1979;41:477-485. [CrossRef][Medline]
Kirby RW, Anderson JW, Sieling B, et al. Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr 1981;34:824-829. [Free Full Text]
Zhang JX, Hallmans G, Andersson H, et al. Effect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies. Am J Clin Nutr 1992;56:99-105. [Free Full Text]
Walters RL, Baird IM, Davies PS, et al. Effects of two types of dietary fibre on faecal steroid and lipid excretion. BMJ 1975;2:536-538.
Kesaniemi YA, Tarpila S, Miettinen TA. Low vs high dietary fiber and serum, biliary, and fecal lipids in middle-aged men. Am J Clin Nutr 1990;51:1007-1012. [Free Full Text]
Abraham ZD, Mehta T. Three-week psyllium-husk supplementation: effect on plasma cholesterol concentrations, fecal steroid excretion, and carbohydrate absorption in men. Am J Clin Nutr 1988;47:67-74. [Free Full Text]
Woods, M. N, Wanke, C. A, Ling, P.-R., Hendricks, K. M, Tang, A. M, Knox, T. A, Andersson, C. E, Dong, K. R, Skinner, S. C, Bistrian, B. R
(2009). Effect of a dietary intervention and n-3 fatty acid supplementation on measures of serum lipid and insulin sensitivity in persons with HIV. Am. J. Clin. Nutr.
90: 1566-1578
[Abstract][Full Text]
Park, Y., Brinton, L. A, Subar, A. F, Hollenbeck, A., Schatzkin, A.
(2009). Dietary fiber intake and risk of breast cancer in postmenopausal women: the National Institutes of Health-AARP Diet and Health Study. Am. J. Clin. Nutr.
90: 664-671
[Abstract][Full Text]
Estruch, R, Martinez-Gonzalez, M A, Corella, D, Basora-Gallisa, J, Ruiz-Gutierrez, V, Covas, M I, Fiol, M, Gomez-Gracia, E, Lopez-Sabater, M C, Escoda, R, Pena, M A, Diez-Espino, J, Lahoz, C, Lapetra, J, Saez, G, Ros, E, on behalf of the PREDIMED Study Investigators,
(2009). Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk. J. Epidemiol. Community Health
63: 582-588
[Abstract][Full Text]
Nahas, R., Moher, M.
(2009). Complementary and alternative medicine for the treatment of type 2 diabetes. cfp
55: 591-596
[Abstract][Full Text]
Shah, M., Chandalia, M., Adams-Huet, B., Brinkley, L. J., Sakhaee, K., Grundy, S. M., Garg, A.
(2009). Effect of a High-Fiber Diet Compared With a Moderate-Fiber Diet on Calcium and Other Mineral Balances in Subjects With Type 2 Diabetes. Diabetes Care
32: 990-995
[Abstract][Full Text]
Hamedani, A., Akhavan, T., Samra, R. A., Anderson, G H.
(2009). Reduced energy intake at breakfast is not compensated for at lunch if a high-insoluble-fiber cereal replaces a low-fiber cereal. Am. J. Clin. Nutr.
89: 1343-1349
[Abstract][Full Text]
Jenkins, D. J. A., Kendall, C. W. C., McKeown-Eyssen, G., Josse, R. G., Silverberg, J., Booth, G. L., Vidgen, E., Josse, A. R., Nguyen, T. H., Corrigan, S., Banach, M. S., Ares, S., Mitchell, S., Emam, A., Augustin, L. S. A., Parker, T. L., Leiter, L. A.
(2008). Effect of a Low-Glycemic Index or a High-Cereal Fiber Diet on Type 2 Diabetes: A Randomized Trial. JAMA
300: 2742-2753
[Abstract][Full Text]
Bassuk, S. S., Manson, J. E.
(2008). Lifestyle and Risk of Cardiovascular Disease and Type 2 Diabetes in Women: A Review of the Epidemiologic Evidence. AMERICAN JOURNAL OF LIFESTYLE MEDICINE
2: 191-213
[Abstract]
Timm, D. A., Slavin, J. L.
(2008). Dietary Fiber and the Relationship to Chronic Diseases. AMERICAN JOURNAL OF LIFESTYLE MEDICINE
2: 233-240
[Abstract]
Bryk, J., Zenati, M., Forsythe, R., Peitzman, A., Ochoa, J. B.
(2008). Effect of Calorically Dense Enteral Nutrition Formulas on Outcome in Critically Ill Trauma and Surgical Patients. JPEN J Parenter Enteral Nutr
32: 6-11
[Abstract][Full Text]
Spear, B. A., Barlow, S. E., Ervin, C., Ludwig, D. S., Saelens, B. E., Schetzina, K. E., Taveras, E. M.
(2007). Recommendations for Treatment of Child and Adolescent Overweight and Obesity. Pediatrics
120: S254-S288
[Abstract][Full Text]
Pittaway, J. K., Ahuja, K. D. K., Robertson, I. K., Ball, M. J.
(2007). Effects of a Controlled Diet Supplemented with Chickpeas on Serum Lipids, Glucose Tolerance, Satiety and Bowel Function. J. Am. Coll. Nutr.
26: 334-340
[Abstract][Full Text]
Kagansky, M., Rimon, E.
(2007). Is There a Difference in Metabolic Outcome Between Different Enteral Formulas?. JPEN J Parenter Enteral Nutr
31: 320-323
[Abstract][Full Text]
Andersson, A., Tengblad, S., Karlstrom, B., Kamal-Eldin, A., Landberg, R., Basu, S., Aman, P., Vessby, B.
(2007). Whole-Grain Foods Do Not Affect Insulin Sensitivity or Markers of Lipid Peroxidation and Inflammation in Healthy, Moderately Overweight Subjects. J. Nutr.
137: 1401-1407
[Abstract][Full Text]
Pereira, M. A
(2006). Weighing in on glycemic index and body weight.. Am. J. Clin. Nutr.
84: 677-679
[Full Text]
Woods, M. N
(2006). Nutrition Academic Award: nutrition education in graduate medical education.. Am. J. Clin. Nutr.
83: 971S-975S
[Abstract][Full Text]
Levinson, Y., Epstein, A., Adler, B., Epstein, L., Dwolatzky, T.
(2006). Successful use of a sucrose-containing enteral formula in diabetic nursing home elderly.. Diabetes Care
29: 698-700
[Full Text]
Morris, J. B., Kays, S. E.
(2005). Total Dietary Fiber Variability in a Cross Section of Crotalaria juncea Genetic Resources. Crop Sci.
45: 1826-1829
[Abstract][Full Text]
Qi, L., Rimm, E., Liu, S., Rifai, N., Hu, F. B.
(2005). Dietary Glycemic Index, Glycemic Load, Cereal Fiber, and Plasma Adiponectin Concentration in Diabetic Men. Diabetes Care
28: 1022-1028
[Abstract][Full Text]
McCarthy, W. J
(2005). More support for dietary patterns involving high-fiber, high-complex carbohydrates. Am. J. Clin. Nutr.
81: 724-724
[Full Text]
Dodin, S., Lemay, A., Jacques, H., Legare, F., Forest, J.-C., Masse, B.
(2005). The Effects of Flaxseed Dietary Supplement on Lipid Profile, Bone Mineral Density, and Symptoms in Menopausal Women: A Randomized, Double-Blind, Wheat Germ Placebo-Controlled Clinical Trial. J. Clin. Endocrinol. Metab.
90: 1390-1397
[Abstract][Full Text]
Ma, Y., Olendzki, B., Chiriboga, D., Hebert, J. R., Li, Y., Li, W., Campbell, M., Gendreau, K., Ockene, I. S.
(2005). Association between Dietary Carbohydrates and Body Weight. Am J Epidemiol
161: 359-367
[Abstract][Full Text]
Kushner, R. F.
(2005). Low-Carbohydrate Diets, Con: The Mythical Phoenix or Credible Science?. Nutr Clin Pract
20: 13-16
[Abstract][Full Text]
Streppel, M. T., Arends, L. R., van 't Veer, P., Grobbee, D. E., Geleijnse, J. M.
(2005). Dietary Fiber and Blood Pressure: A Meta-analysis of Randomized Placebo-Controlled Trials. Arch Intern Med
165: 150-156
[Abstract][Full Text]
Gonlachanvit, S, Coleski, R, Owyang, C, Hasler, W.
(2004). Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers. Gut
53: 1577-1582
[Abstract][Full Text]
Katz, D. L., Evans, M. A., Chan, W., Nawaz, H., Comerford, B. P., Hoxley, M. L., Njike, V. Y., Sarrel, P. M.
(2004). Oats, Antioxidants and Endothelial Function in Overweight, Dyslipidemic Adults. J. Am. Coll. Nutr.
23: 397-403
[Abstract][Full Text]
Rizkalla, S. W., Taghrid, L., Laromiguiere, M., Huet, D., Boillot, J., Rigoir, A., Elgrably, F., Slama, G.
(2004). Improved Plasma Glucose Control, Whole-Body Glucose Utilization, and Lipid Profile on a Low-Glycemic Index Diet in Type 2 Diabetic Men: A randomized controlled trial. Diabetes Care
27: 1866-1872
[Abstract][Full Text]
O'Donovan, D. G., Doran, S., Feinle-Bisset, C., Jones, K. L., Meyer, J. H., Wishart, J. M., Morris, H. A., Horowitz, M.
(2004). Effect of Variations in Small Intestinal Glucose Delivery on Plasma Glucose, Insulin, and Incretin Hormones in Healthy Subjects and Type 2 Diabetes. J. Clin. Endocrinol. Metab.
89: 3431-3435
[Abstract][Full Text]
Slyper, A. H.
(2004). The Pediatric Obesity Epidemic: Causes and Controversies. J. Clin. Endocrinol. Metab.
89: 2540-2547
[Abstract][Full Text]
Gross, L. S, Li, L., Ford, E. S, Liu, S.
(2004). Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am. J. Clin. Nutr.
79: 774-779
[Abstract][Full Text]
Pereira, M. A., O'Reilly, E., Augustsson, K., Fraser, G. E., Goldbourt, U., Heitmann, B. L., Hallmans, G., Knekt, P., Liu, S., Pietinen, P., Spiegelman, D., Stevens, J., Virtamo, J., Willett, W. C., Ascherio, A.
(2004). Dietary Fiber and Risk of Coronary Heart Disease: A Pooled Analysis of Cohort Studies. Arch Intern Med
164: 370-376
[Abstract][Full Text]
Anderson, J. W., Randles, K. M., Kendall, C. W. C., Jenkins, D. J. A.
(2004). Carbohydrate and Fiber Recommendations for Individuals with Diabetes: A Quantitative Assessment and Meta-Analysis of the Evidence. J. Am. Coll. Nutr.
23: 5-17
[Abstract][Full Text]
McKeown, N. M., Meigs, J. B., Liu, S., Saltzman, E., Wilson, P. W.F., Jacques, P. F.
(2004). Carbohydrate Nutrition, Insulin Resistance, and the Prevalence of the Metabolic Syndrome in the Framingham Offspring Cohort. Diabetes Care
27: 538-546
[Abstract][Full Text]
Hendricks, K. M, Dong, K. R, Tang, A. M, Ding, B., Spiegelman, D., Woods, M. N, Wanke, C. A
(2003). High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition. Am. J. Clin. Nutr.
78: 790-795
[Abstract][Full Text]
Kelley, D. E
(2003). Sugars and starch in the nutritional management of diabetes mellitus. Am. J. Clin. Nutr.
78: 858S-864
[Abstract][Full Text]
Sharpless, J. L.
(2003). Polycystic Ovary Syndrome and the Metabolic Syndrome. Clin. Diabetes
21: 154-161
[Abstract][Full Text]
Anderson, J. W., Kendall, C. W.C., Jenkins, D. J.A.
(2003). Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies. J. Am. Coll. Nutr.
22: 331-339
[Abstract][Full Text]
Jenkins, D. J., Kendall, C. W., Marchie, A., Jenkins, A. L, Augustin, L. S., Ludwig, D. S, Barnard, N. D, Anderson, J. W
(2003). Type 2 diabetes and the vegetarian diet. Am. J. Clin. Nutr.
78: 610S-616
[Abstract][Full Text]
Brand-Miller, J., Hayne, S., Petocz, P., Colagiuri, S.
(2003). Low-Glycemic Index Diets in the Management of Diabetes: A meta-analysis of randomized controlled trials. Diabetes Care
26: 2261-2267
[Abstract][Full Text]
Schafer, G., Schenk, U., Ritzel, U., Ramadori, G., Leonhardt, U.
(2003). Comparison of the effects of dried peas with those of potatoes in mixed meals on postprandial glucose and insulin concentrations in patients with type 2 diabetes. Am. J. Clin. Nutr.
78: 99-103
[Abstract][Full Text]
Geleva, D., Thomas, W., Gannon, M. C., Keenan, J. M.
(2003). A Solubilized Cellulose Fiber Decreases Peak Postprandial Cholecystokinin Concentrations after a Liquid Mixed Meal in Hypercholesterolemic Men and Women. J. Nutr.
133: 2194-2203
[Abstract][Full Text]
Yeh, G. Y., Eisenberg, D. M., Kaptchuk, T. J., Phillips, R. S.
(2003). Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes. Diabetes Care
26: 1277-1294
[Abstract][Full Text]
Liu, S.
(2003). Whole-grain foods, dietary fiber, and type 2 diabetes: searching for a kernel of truth. Am. J. Clin. Nutr.
77: 527-529
[Full Text]
Beauchesne-Rondeau, E., Gascon, A., Bergeron, J., Jacques, H.
(2003). Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry. Am. J. Clin. Nutr.
77: 587-593
[Abstract][Full Text]
Juntunen, K. S, Laaksonen, D. E, Poutanen, K. S, Niskanen, L. K, Mykkanen, H. M
(2003). High-fiber rye bread and insulin secretion and sensitivity in healthy postmenopausal women. Am. J. Clin. Nutr.
77: 385-391
[Abstract][Full Text]
Chen, H.-L., Sheu, W. H.-H., Tai, T.-S., Liaw, Y.-P., Chen, Y.-C.
(2003). Konjac Supplement Alleviated Hypercholesterolemia and Hyperglycemia in Type 2 Diabetic Subjects--A Randomized Double-Blind Trial. J. Am. Coll. Nutr.
22: 36-42
[Abstract][Full Text]
Franz, M. J.
(2003). So Many Nutrition Recommendations--Contradictory or Compatible?. Diabetes Spectr.
16: 56-63
[Full Text]
Franz, M J, Warshaw, H, Daly, A E, Green-Pastors, J, Arnold, M S, Bantle, J
(2003). Evolution of diabetes medical nutrition therapy. Postgrad. Med. J.
79: 30-35
[Abstract][Full Text]
Nelson, K. M., Reiber, G., Boyko, E. J.
(2002). Diet and Exercise Among Adults With Type 2 Diabetes: Findings from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care
25: 1722-1728
[Abstract][Full Text]
Franz, M. J.
(2002). 2002 Diabetes Nutrition Recommendations: Grading the Evidence. The Diabetes Educator
28: 756-766
Jenkins, D. J. A., Kendall, C. W. C., Augustin, L. S. A., Martini, M. C., Axelsen, M., Faulkner, D., Vidgen, E., Parker, T., Lau, H., Connelly, P. W., Teitel, J., Singer, W., Vandenbroucke, A. C., Leiter, L. A., Josse, R. G.
(2002). Effect of Wheat Bran on Glycemic Control and Risk Factors for Cardiovascular Disease in Type 2 Diabetes. Diabetes Care
25: 1522-1528
[Abstract][Full Text]
McKeown, N. M, Meigs, J. B, Liu, S., Wilson, P. W., Jacques, P. F
(2002). Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am. J. Clin. Nutr.
76: 390-398
[Abstract][Full Text]
Liu, S.
(2002). Intake of Refined Carbohydrates and Whole Grain Foods in Relation to Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease. J. Am. Coll. Nutr.
21: 298-306
[Abstract][Full Text]
Franz, M. J., Bantle, J. P.
(2002). Response to the Diabetes Nutrition Study Group of the European Association for the Study of Diabetes. Diabetes Care
25: 1258-1259
[Full Text]
Mann, J., Hermansen, K., Vessby, B., Toeller, M.
(2002). Evidence-Based Nutritional Recommendations for the Treatment and Prevention of Diabetes and Related Complications: A European perspective. Diabetes Care
25: 1256-1258
[Full Text]
Pereira, M. A, Jacobs, D. R Jr, Pins, J. J, Raatz, S. K, Gross, M. D, Slavin, J. L, Seaquist, E. R
(2002). Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am. J. Clin. Nutr.
75: 848-855
[Abstract][Full Text]
Liu, S., Buring, J. E., Sesso, H. D., Rimm, E. B., Willett, W. C., Manson, J. E.
(2002). A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol
39: 49-56
[Abstract][Full Text]
Franz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J.-L., Garg, A., Holzmeister, L. A., Hoogwerf, B., Mayer-Davis, E., Mooradian, A. D., Purnell, J. Q., Wheeler, M.
(2002). Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications. Diabetes Care
25: 148-198
[Full Text]
Hayes, C.
(2002). Diabetes Bars and Beverages: The Benefits and the Controversies. Diabetes Spectr.
15: 11-14
[Full Text]
Henry, R. R.
(2001). Preventing Cardiovascular Complications of Type 2 Diabetes: Focus on Lipid Management. Clin. Diabetes
19: 113-120
[Abstract][Full Text]
Barner, C., Wylie-Rosett, J., Gans, K.
(2001). WAVE: A Pocket Guide for a Brief Nutrition Dialogue in Primary Care. The Diabetes Educator
27: 352-362
Rayner, C. K., Samsom, M., Jones, K. L., Horowitz, M.
(2001). Relationships of Upper Gastrointestinal Motor and Sensory Function With Glycemic Control. Diabetes Care
24: 371-381
[Abstract][Full Text]
Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W. Jr, Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., Lichtenstein, A. H., Mitch, W. E., Mullis, R., Robinson, K., Wylie-Rosett, J., St. Jeor, S., Suttie, J., Tribble, D. L., Bazzarre, T. L.
(2001). AHA Scientific Statement: AHA Dietary Guidelines: Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association. J. Nutr.
131: 132-146
[Full Text]
Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W. Jr, Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., Lichtenstein, A. H., Mitch, W. E., Mullis, R., Robinson, K., Wylie-Rosett, J., St. Jeor, S., Suttie, J., Tribble, D. L., Bazzarre, T. L.
(2000). AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association. Stroke
31: 2751-2766
[Full Text]
Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W. Jr, Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., Lichtenstein, A. H., Mitch, W. E., Mullis, R., Robinson, K., Wylie-Rosett, J., St. Jeor, S., Suttie, J., Tribble, D. L., Bazzarre, T. L.
(2000). AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association. Circulation
102: 2284-2299
[Full Text]
Anderson, J. W., Konz, E. C., Jenkins, D. J. A.
(2000). Health Advantages and Disadvantages of Weight-Reducing Diets: A Computer Analysis and Critical Review. J. Am. Coll. Nutr.
19: 578-590
[Abstract][Full Text]
Campbell, S.
(2000). Management of Type 2 Diabetes in the Geriatric Patient. Journal of Pharmacy Practice
13: 263-276
[Abstract]
(2000). High-Fiber Diet for Patients with Diabetes. JWatch Gastroenterology
2000: 20-20
[Full Text]
(2000). High-Fiber Diet for Patients with Diabetes. JWatch General
2000: 2-2
[Full Text]
Rendell, M.
(2000). Dietary Treatment of Diabetes Mellitus. NEJM
342: 1440-1441
[Full Text]